Moderna’s coronavirus vaccine has become the second to receive approval from Europe’s medicines regulator, as authorities accelerate the roll-out of jabs aimed at curbing the pandemic amid worries about more infectious variants.

Following the green light from the European Medicines Agency (EMA), the final step is approval by the European commission which is expected to quickly follow.